Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HSCT関連血栓性微小血管症の治療のための組成物及び方法
Document Type and Number:
Japanese Patent JP6654137
Kind Code:
B2
Abstract:
Disclosed are drugs capable of inhibiting the complement pathway for use for treating hematopoietic stem cell transplant (HSCT) associated thrombotic microangiopathy (HSCT-TMA, also called TA-TMA) in a subject that has undergone an HSCT. Also disclosed are methods of using drugs capable of inhibiting the complement pathway for use for treating hematopoietic stem cell transplant (HSCT) associated thrombotic microangiopathy (HSCT-TMA) in a subject that has undergone an HSCT.

Inventors:
Jodel, Sonata
Ruskin, Benjamin, Elle.
Application Number:
JP2016542879A
Publication Date:
February 26, 2020
Filing Date:
September 16, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Children's Hospital Medical Center
International Classes:
A61K39/395; A61P7/00; A61P37/06
Other References:
British Journal of Haematology,2013年 1月 7日,161,p.279-280
薬物血中濃度測定の重要性 ~TDM(治療薬物モニタリング)の基礎知識~,広島市医師会だより,2011年 6月15日,第542号 付録,p,2-5
The Binding Site Group Ltd,CH50 Eq Enzyme Immunoassay Kit, Product code: MK095,2009年,Version 21,p.1-3
Biol Blood Marrow Transplant.,2014年 4月,20(4),p.518-525
Blood,2002年,100,p.2374-2386
Number of transplant by year by donor type and cell source,Transplant Activity Report[online],retrieved on 2018 Nov 22,Health Resources and Services Administration,Table 3,retrieved from the Internet
Bone Marrow Transplantation,2016年,51,p.786-792
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto